A Conceptual Reference Framework for Enterprise Resilience Enhancement

[EN] Enterprise resilience is a key capacity to guarantee enterprises' long-term continuity. This paper proposes the enterprise resilience Conceptual Reference Framework to characterize enterprise resilience capacity. The framework is composed of 71 disruptive events that enterprises consider as endangerments to their continuity. The framework also comprises constituent capabilities of enterprise resilience in terms of preparedness and recovery capabilities and elements that support the transition from the AS IS situation to the TO BE one, which are preventive actions (for preparedness capability) and knowledge registration actions (for recovery capability). From the preparedness perspective, 403 preventive actions are currently defined. Each preventive action is specific for every disruptive event. However, it is worth noting that a preventive action can also be applied to different disruptive events. From the recovery perspective, the proposed framework indicates knowledge registration related to (i) the occurrence of disruptive events; (ii) the recovery actions performed to re-establish the normal enterprise operation level. Further research lines are addressed to develop quantitative methods and tools to assess the extent of enterprises' resilience following the foundations of the proposed conceptual framework.This work was supported in part by the European Commission under the Grant Agreement No. 691249 and the Spanish State Research Agency (Agencia Estatal de Investigacion) under the Reference No. RTI2018-101344-B-I00-AR.Sanchis, R.; Canetta, L.; Poler, R. (2020). A Conceptual Reference Framework for Enterprise Resilience Enhancement. Sustainability. 12(4):1-27. https://doi.org/10.3390/su12041464S127124Christopher, M., & Peck, H. (2004). Building the Resilient Supply Chain. The International Journal of Logistics Management, 15(2), 1-14. doi:10.1108/09574090410700275Craighead, C. W., Blackhurst, J., Rungtusanatham, M. J., & Handfield, R. B. (2007). The Severity of Supply Chain Disruptions: Design Characteristics and Mitigation Capabilities. Decision Sciences, 38(1), 131-156. doi:10.1111/j.1540-5915.2007.00151.xOhio History Central, Dayton, Ohio, General Motors Strikehttps://ohiohistorycentral.org/w/Dayton,_Ohio,_General_Motors_Strike_(1996)Blackhurst *, J., Craighead, C. W., Elkins, D., & Handfield, R. B. (2005). An empirically derived agenda of critical research issues for managing supply-chain disruptions. International Journal of Production Research, 43(19), 4067-4081. doi:10.1080/00207540500151549Holling, C. S. (1973). Resilience and Stability of Ecological Systems. Annual Review of Ecology and Systematics, 4(1), 1-23. doi:10.1146/annurev.es.04.110173.000245Lomba-Fernández, Hernantes, & Labaka. (2019). Guide for Climate-Resilient Cities: An Urban Critical Infrastructures Approach. Sustainability, 11(17), 4727. doi:10.3390/su11174727The Importance of Resilience. Why Do Some Children Bounce Back from Adversity Better Than Others—and Can That Quality Be Taught?http://content.time.com/time/magazine/article/0,9171,1015897,00.htmlSmith, P., Hutchison, D., Sterbenz, J. P. G., Schöller, M., Fessi, A., Karaliopoulos, M., … Plattner, B. (2011). Network resilience: a systematic approach. IEEE Communications Magazine, 49(7), 88-97. doi:10.1109/mcom.2011.5936160Stoltz, P. G. (2003). Building resilience for uncertain times. Leader to Leader, 2004(31), 16-20. doi:10.1002/ltl.58Labaka, L., Hernantes, J., & Sarriegi, J. M. (2015). Resilience framework for critical infrastructures: An empirical study in a nuclear plant. Reliability Engineering & System Safety, 141, 92-105. doi:10.1016/j.ress.2015.03.009Home, J. F., & Orr, J. E. (1997). Assessing behaviors that create resilient organizations. Employment Relations Today, 24(4), 29-39. doi:10.1002/ert.3910240405Riolli, L., & Savicki, V. (2003). Information system organizational resilience. Omega, 31(3), 227-233. doi:10.1016/s0305-0483(03)00023-9Madni, A. M., & Jackson, S. (2009). Towards a Conceptual Framework for Resilience Engineering. IEEE Systems Journal, 3(2), 181-191. doi:10.1109/jsyst.2009.2017397Resiliencia Organizacional. Transformando la Adversidad en Fuente de Innovaciónhttp://www.gerenciadinamicahoy.com/2011/02/resiliencia-organizacional.htmlThe Agility Advantage: A Survival Guide for Complex Enterprises and Endeavorshttps://apps.dtic.mil/dtic/tr/fulltext/u2/a631225.pdfGilly, J.-P., Kechidi, M., & Talbot, D. (2014). Resilience of organisations and territories: The role of pivot firms. European Management Journal, 32(4), 596-602. doi:10.1016/j.emj.2013.09.004Kamalahmadi, M., & Parast, M. M. (2016). A review of the literature on the principles of enterprise and supply chain resilience: Major findings and directions for future research. International Journal of Production Economics, 171, 116-133. doi:10.1016/j.ijpe.2015.10.023Mamouni Limnios, E. A., Mazzarol, T., Ghadouani, A., & Schilizzi, S. G. M. (2014). The Resilience Architecture Framework: Four organizational archetypes. European Management Journal, 32(1), 104-116. doi:10.1016/j.emj.2012.11.007Cabral, I., Grilo, A., & Cruz-Machado, V. (2012). A decision-making model for Lean, Agile, Resilient and Green supply chain management. International Journal of Production Research, 50(17), 4830-4845. doi:10.1080/00207543.2012.657970Pettit, T. J., Croxton, K. L., & Fiksel, J. (2013). Ensuring Supply Chain Resilience: Development and Implementation of an Assessment Tool. Journal of Business Logistics, 34(1), 46-76. doi:10.1111/jbl.12009Soni, U., Jain, V., & Kumar, S. (2014). Measuring supply chain resilience using a deterministic modeling approach. Computers & Industrial Engineering, 74, 11-25. doi:10.1016/j.cie.2014.04.019Munoz, A., & Dunbar, M. (2015). On the quantification of operational supply chain resilience. International Journal of Production Research, 53(22), 6736-6751. doi:10.1080/00207543.2015.1057296Kim, Y., Chen, Y.-S., & Linderman, K. (2014). Supply network disruption and resilience: A network structural perspective. Journal of Operations Management, 33-34(1), 43-59. doi:10.1016/j.jom.2014.10.006Erol, O., Sauser, B. J., & Mansouri, M. (2010). A framework for investigation into extended enterprise resilience. Enterprise Information Systems, 4(2), 111-136. doi:10.1080/17517570903474304Pettit, T. J., Fiksel, J., & Croxton, K. L. (2010). ENSURING SUPPLY CHAIN RESILIENCE: DEVELOPMENT OF A CONCEPTUAL FRAMEWORK. Journal of Business Logistics, 31(1), 1-21. doi:10.1002/j.2158-1592.2010.tb00125.xLee, A. V., Vargo, J., & Seville, E. (2013). Developing a Tool to Measure and Compare Organizations’ Resilience. Natural Hazards Review, 14(1), 29-41. doi:10.1061/(asce)nh.1527-6996.0000075Sanchis, R., & Poler, R. (2019). Enterprise Resilience Assessment—A Quantitative Approach. Sustainability, 11(16), 4327. doi:10.3390/su11164327How Poisoned Tylenol Became a Crisis-Management Teaching Modelhttps://time.com/3423136/tylenol-deaths-1982/Benzene Incident Haunts Perrierhttps://news.google.com/newspapers?nid=1345&dat=19910219&id=L8gSAAAAIBAJ&sjid=CfoDAAAAIBAJ&pg=3676,2504946&hl=esBDO Technology Risk Factor Reporthttps://www.bdo.com/getattachment/d10c417f-beb7-4bb9-8835-2b2ec727ce2b/attachment.aspx?2017-Technology-Riskfactor-Report-Brochure_WEB.pdfSupply Chain Resilience Report 2015http://www.bcifiles.com/bci-supply-chain-resilience-2015.pdfCabero Almenara, J., & Barroso Osuna, J. (2013). La utilización del juicio de experto para la evaluación de TIC: el Coeficiente de competencia experta. Bordón. Revista de Pedagogía, 65(2), 25-38. doi:10.13042/brp.2013.65202Comfort, L. K., Sungu, Y., Johnson, D., & Dunn, M. (2001). Complex Systems in Crisis: Anticipation and Resilience in Dynamic Environments. Journal of Contingencies and Crisis Management, 9(3), 144-158. doi:10.1111/1468-5973.00164Ponomarov, S. Y., & Holcomb, M. C. (2009). Understanding the concept of supply chain resilience. The International Journal of Logistics Management, 20(1), 124-143. doi:10.1108/09574090910954873Haimes, Y. Y., Crowther, K., & Horowitz, B. M. (2008). Homeland security preparedness: Balancing protection with resilience in emergent systems. Systems Engineering, 11(4), 287-308. doi:10.1002/sys.20101Svensson, G. (2002). A conceptual framework of vulnerability in firms’ inbound and outbound logistics flows. International Journal of Physical Distribution & Logistics Management, 32(2), 110-134. doi:10.1108/09600030210421723Kleindorfer, P. R., & Saad, G. H. (2009). Managing Disruption Risks in Supply Chains. Production and Operations Management, 14(1), 53-68. doi:10.1111/j.1937-5956.2005.tb00009.xHendricks, K. B., Singhal, V. R., & Zhang, R. (2008). The effect of operational slack, diversification, and vertical relatedness on the stock market reaction to supply chain disruptions. Journal of Operations Management, 27(3), 233-246. doi:10.1016/j.jom.2008.09.001Natarajarathinam, M., Capar, I., & Narayanan, A. (2009). Managing supply chains in times of crisis: a review of literature and insights. International Journal of Physical Distribution & Logistics Management, 39(7), 535-573. doi:10.1108/09600030910996251Cucchiella, F., & Gastaldi, M. (2006). Risk management in supply chain: a real option approach. Journal of Manufacturing Technology Management, 17(6), 700-720. doi:10.1108/17410380610678756Sanchis, R., Sanchis-Gisbert, M. R., & Poler, R. (2020). Conceptualisation of the Three-Dimensional Matrix of Collaborative Knowledge Barriers. Sustainability, 12(3), 1279. doi:10.3390/su12031279Sanchis, R., & Poler, R. (2019). Origins of Disruptions Sources Framework to Support the Enterprise Resilience Analysis. IFAC-PapersOnLine, 52(13), 2062-2067. doi:10.1016/j.ifacol.2019.11.509Bhamra, R., Dani, S., & Burnard, K. (2011). Resilience: the concept, a literature review and future directions. International Journal of Production Research, 49(18), 5375-5393. doi:10.1080/00207543.2011.563826Ivanov, D., Dolgui, A., Sokolov, B., & Ivanova, M. (2017). Literature review on disruption recovery in the supply chain. International Journal of Production Research, 55(20), 6158-6174. doi:10.1080/00207543.2017.1330572Paton, D., & Johnston, D. (2001). Disasters and communities: vulnerability, resilience and preparedness. Disaster Prevention and Management: An International Journal, 10(4), 270-277. doi:10.1108/eum0000000005930Luers, A. L., Lobell, D. B., Sklar, L. S., Addams, C. L., & Matson, P. A. (2003). A method for quantifying vulnerability, applied to the agricultural system of the Yaqui Valley, Mexico. Global Environmental Change, 13(4), 255-267. doi:10.1016/s0959-3780(03)00054-2Dovers, S. R., & Handmer, J. W. (1992). Uncertainty, sustainability and change. Global Environmental Change, 2(4), 262-276. doi:10.1016/0959-3780(92)90044-8Ricciardi, F., Zardini, A., & Rossignoli, C. (2016). Organizational dynamism and adaptive business model innovation: The triple paradox configuration. Journal of Business Research, 69(11), 5487-5493. doi:10.1016/j.jbusres.2016.04.154Tomlin, B. (2006). On the Value of Mitigation and Contingency Strategies for Managing Supply Chain Disruption Risks. Management Science, 52(5), 639-657. doi:10.1287/mnsc.1060.0515Sanchis, R., & Poler, R. (2019). Mitigation proposal for the enhancement of enterprise resilience against supply disruptions. IFAC-PapersOnLine, 52(13), 2833-2838. doi:10.1016/j.ifacol.2019.11.638Comfort, L. K., Siciliano, M. D., & Okada, A. (2011). Resilience, Entropy, and Efficiency in Crisis Management: The January 12, 2010, Haiti Earthquake. Risk, Hazards & Crisis in Public Policy, 2(3), 1-25. doi:10.2202/1944-4079.1089Self-Assessment Tool to Improve Enterprise Resilience—SATIERhttp://satier.blogs.upv.es/files/2020/02/Questionnaire_Offline_SATIER_English.zi

SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy

We report onset, course, correlations with comorbidities, and diagnostic accuracy of nasopharyngeal swab in 539 individuals suspected to carry SARS-COV-2 admitted to the hospital of Crema, Italy. All individuals underwent clinical and laboratory exams, SARS-COV-2 reverse transcriptase-polymerase chain reaction on nasopharyngeal swab, and chest X-ray and/or computed tomography (CT). Data on onset, course, comorbidities, number of drugs including angiotensin converting enzyme (ACE) inhibitors and angiotensin-II-receptor antagonists (sartans), follow-up swab, pharmacological treatments, non-invasive respiratory support, ICU admission, and deaths were recorded. Among 411 SARS-COV-2 patients (67.7% males) median age was 70.8 years (range 5-99). Chest CT was performed in 317 (77.2%) and showed interstitial pneumonia in 304 (96%). Fatality rate was 17.5% (74% males), with 6.6% in 60-69 years old, 21.1% in 70-79 years old, 38.8% in 80-89 years old, and 83.3% above 90 years. No death occurred below 60 years. Non-invasive respiratory support rate was 27.2% and ICU admission 6.8%. Charlson comorbidity index and high Creactive protein at admission were significantly associated with death. Use of ACE inhibitors or sartans was not associated with outcomes. Among 128 swab negative patients at admission (63.3% males) median age was 67.7 years (range 1-98). Chest CT was performed in 87 (68%) and showed interstitial pneumonia in 76 (87.3%). Follow-up swab turned positive in 13 of 32 patients. Using chest CT at admission as gold standard on the entire study population of 539 patients, nasopharyngeal swab had 80% accuracy. Comorbidity network analysis revealed a more homogenous distribution 60-40 aged SARS-COV-2 patients across diseases and a crucial different interplay of diseases in the networks of deceased and survived patients. SARS-CoV-2 caused high mortality among patients older than 60 years and correlated with pre-existing multiorgan impairment. Copyright

Partial Dynamical Symmetry in the Symplectic Shell Model

We present an example of a partial dynamical symmetry (PDS) in an interacting fermion system and demonstrate the close relationship of the associated Hamiltonians with a realistic quadrupole-quadrupole interaction, thus shedding new light on this important interaction. Specifically, in the framework of the symplectic shell model of nuclei, we prove the existence of a family of fermionic Hamiltonians with partial SU(3) symmetry. We outline the construction process for the PDS eigenstates with good symmetry and give analytic expressions for the energies of these states and E2 transition strengths between them. Characteristics of both pure and mixed-symmetry PDS eigenstates are discussed and the resulting spectra and transition strengths are compared to those of real nuclei. The PDS concept is shown to be relevant to the description of prolate, oblate, as well as triaxially deformed nuclei. Similarities and differences between the fermion case and the previously established partial SU(3) symmetry in the Interacting Boson Model are considered.Comment: 9 figure

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent vs combination and carboplatin vs cisplatin) in the treatment of advanced ovarian cancer. Also, to investigate whether well-defined patient subgroups benefit more or less from cisplatin- or carboplatin-based therapy. Meta-analyses were based on updated individual patient data from all available randomized controlled trials (published and unpublished), including 37 trials, 5667 patients and 4664 deaths. The results suggest that platinum-based chemotherapy is better than non-platinum therapy, show a trend in favour of platinum combinations over single-agent platinum, and suggest that cisplatin and carboplatin are equally effective. There is no good evidence that cisplatin is more or less effective than carboplatin in any particular subgroup of patients

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

Purpose: To determine the place of single-agent paclitaxel compared with nonanthracycline combination chemotherapy as front-line therapy in metastatic breast cancer. Patients and Methods: patients with previously untreated metastatic breast cancer were randomized to receive either paclitaxel 200 mg/m(2) intravenously (IV) over 3 hours for eight cycles (24 weeks) or standard cyclophosphamide 100 mg/m(2)/d orally on days 1 to 14, methotrexate 40 mg/m(2) IV on days 1 and 8, fluorouracil 600 mg/m(2) IV on days 1 and 8, and prednisone 40 mg/m2/d orally on days 1 to 14 (CMFP) for six cycles (24 weeks) with epirubicin recommended as second-line therapy. Results: A total of 209 eligible patients were randomized with a median survival duration of 17.3 months for paclitaxel and 13.9 months for CMFP. Multivariate analysis showed that patients who received paclitaxel survived significantly longer than those who received CMFP (P = .025). Paclitaxel produced significantly less severe leukopenia, thrombocytopenia, mucositis, documented infections (all P < .001), nausea or vomiting (P = .003), and fever without documented infection (P = .007), and less hospitalization for febrile neutropenia than did CMFP (P = .001). Alopecia, peripheral neuropathy, and myalgia or arthralgia were more severe with paclitaxel (all P < .0001). Overall, quality of life was similar for both treatments (P greater than or equal to .07). Conclusion: Initial paclitaxel was associated with significantly less myelosuppression and fewer infections, with longer survival and similar quality of life and control of metastatic breast cancer compared with CMFP. (C) 1999 by American Society of Clinical Oncology

Type III Nrg1 Back Signaling Enhances Functional TRPV1 along Sensory Axons Contributing to Basal and Inflammatory Thermal Pain Sensation

Type III Nrg1, a member of the Nrg1 family of signaling proteins, is expressed in sensory neurons, where it can signal in a bi-directional manner via interactions with the ErbB family of receptor tyrosine kinases (ErbB RTKs) [1]. Type III Nrg1 signaling as a receptor (Type III Nrg1 back signaling) can acutely activate phosphatidylinositol-3-kinase (PtdIns3K) signaling, as well as regulate levels of α7* nicotinic acetylcholine receptors, along sensory axons [2]. Transient receptor potential vanilloid 1 (TRPV1) is a cation-permeable ion channel found in primary sensory neurons that is necessary for the detection of thermal pain and for the development of thermal hypersensitivity to pain under inflammatory conditions [3]. Cell surface expression of TRPV1 can be enhanced by activation of PtdIns3K [4], [5], [6], making it a potential target for regulation by Type III Nrg1. We now show that Type III Nrg1 signaling in sensory neurons affects functional axonal TRPV1 in a PtdIns3K-dependent manner. Furthermore, mice heterozygous for Type III Nrg1 have specific deficits in their ability to respond to noxious thermal stimuli and to develop capsaicin-induced thermal hypersensitivity to pain. Cumulatively, these results implicate Type III Nrg1 as a novel regulator of TRPV1 and a molecular mediator of nociceptive function

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Background: B-cell anomalies play a role in the pathogenesis of membranous nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for inducing and maintaining a complete or partial remission of proteinuria in patients with this condition. Methods: We randomly assigned patients who had membranous nephropathy, proteinuria of at least 5 g per 24 hours, and a quantified creatinine clearance of at least 40 ml per minute per 1.73 m(2) of body-surface area and had been receiving angiotensin-system blockade for at least 3 months to receive intravenous rituximab (two infusions, 1000 mg each, administered 14 days apart; repeated at 6 months in case of partial response) or oral cyclosporine (starting at a dose of 3.5 mg per kilogram of body weight per day for 12 months). Patients were followed for 24 months. The primary outcome was a composite of complete or partial remission of proteinuria at 24 months. Laboratory variables and safety were also assessed. Results: A total of 130 patients underwent randomization. At 12 months, 39 of 65 patients (60%) in the rituximab group and 34 of 65 (52%) in the cyclosporine group had a complete or partial remission (risk difference, 8 percentage points; 95% confidence interval [CI], -9 to 25; P=0.004 for noninferiority). At 24 months, 39 patients (60%) in the rituximab group and 13 (20%) in the cyclosporine group had a complete or partial remission (risk difference, 40 percentage points; 95% CI, 25 to 55; P<0.001 for both noninferiority and superiority). Among patients in remission who tested positive for anti-phospholipase A(2) receptor (PLA2R) antibodies, the decline in autoantibodies to anti-PLA2R was faster and of greater magnitude and duration in the rituximab group than in the cyclosporine group. Serious adverse events occurred in 11 patients (17%) in the rituximab group and in 20 (31%) in the cyclosporine group (P=0.06). Conclusions: Rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and was superior in maintaining proteinuria remission up to 24 months. (Funded by Genentech and the Fulk Family Foundation; MENTOR ClinicalTrials.gov number, .) In a randomized, controlled trial involving patients with membranous nephropathy, rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and was superior in maintaining proteinuria remission for up to 24 months.Genentech; Fulk Family Foundation6 month embargo; published July 4, 2019This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

African Americans have a significantly higher risk of developing chronic kidney disease, especially focal segmental glomerulosclerosis -, than European Americans. Two coding variants (G1 and G2) in the APOL1 gene play a major role in this disparity. While 13% of African Americans carry the high-risk recessive genotypes, only a fraction of these individuals develops FSGS or kidney failure, indicating the involvement of additional disease modifiers. Here, we show that the presence of the APOL1 p.N264K missense variant, when co-inherited with the G2 APOL1 risk allele, substantially reduces the penetrance of the G1G2 and G2G2 high-risk genotypes by rendering these genotypes low-risk. These results align with prior functional evidence showing that the p.N264K variant reduces the toxicity of the APOL1 high-risk alleles. These findings have important implications for our understanding of the mechanisms of APOL1-associated nephropathy, as well as for the clinical management of individuals with high-risk genotypes that include the G2 allele

Fetal programming of neuropsychiatric disorders by maternal pregnancy depression: a systematic mini review

BACKGROUND: Maternal depression complicates a large proportion of pregnancies. Current evidence shows numerous harmful effects on the offspring. Reviews, which include depression, concluded that stress has harmful effects on the offspring's outcomes neuro-cognitive development, temperament traits, and mental disorders. OBJECTIVE: This mini review of recent studies, sought to narrow the scope of exposure and identify studies specifically assessing prenatal depression and offspring neuropsychiatric outcomes. STUDY ELIGIBILITY CRITERIA: The review included longitudinal, cohort, cross-sectional, clinical, quasi-experimental, epidemiological, or intervention study designs published in English from 2014 to 2018. PARTICIPANTS: Study populations included mother-child dyads, mother-father-child triads, mother-alternative caregiver-child triads, and family studies utilizing sibling comparisons. METHODS: We searched PubMED and Web of Science. Study inclusion and data extraction were based on standardized templates. The quality of evidence was assessed using the Newcastle-Ottawa Scale (NOS). RESULTS: Thirteen studies examining neuropsychiatric outcomes were included. We judged the evidence to be moderate to high quality. CONCLUSIONS: Our review supports that maternal prenatal depression is associated with neuropsychiatric adversities in children.Peer reviewe